<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39457242</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1660-4601</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>24</Day></PubDate></JournalIssue><Title>International journal of environmental research and public health</Title><ISOAbbreviation>Int J Environ Res Public Health</ISOAbbreviation></Journal><ArticleTitle>Panic in the Pandemic: Determinants of Vaccine Hesitancy and the Dilemma of Public Health Information Sharing during the COVID-19 Pandemic in Sri Lanka.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1268</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijerph21101268</ELocationID><Abstract><AbstractText>Vaccine hesitancy, a pressing global challenge in vaccination programs, was significantly amplified during the COVID-19 pandemic. The proliferation of misinformation, including false claims and rumours, and the influence of anti-vaccine movements fuelled hesitancy. This study aims to explore the socio-economic determinants that influenced vaccine hesitancy and the impact of public health information sharing in Sri Lanka during the pandemic. The study employed a comprehensive mixed-method approach for data collection, administrating a household survey <i>(n</i> = 3330) and 206 semi-structured interviews. The survey results indicated that 37.8% (<i>n</i> = 3113) of respondents delayed or rejected vaccines for various reasons, the leading cause being the fear of side effects of the vaccine. Although fear of side effects was the prime reason for rejection (<i>n</i> = 1176, 46.29%), respondents demonstrated an extremely poor understanding of the potential side effects of vaccines, which was 55.39% (<i>n</i> = 3113). Notably, 84.60% (<i>n</i> = 3113) were unaware of the vaccine development process. Multivariate logistic regression analysis showed that middle-income people (AOR-0.42) and females (0.65) were less likely not to make decisions based on scientific information compared to underprivileged people and males. The survey also revealed that strong belief in the use of traditional medicines and remedies and religious beliefs (<i>n</i> = 1176, 3.95%) were among the main reasons for hesitancy. The findings illustrate that misinformation, lack of health knowledge, and lack of understanding to seek scientific information have fuelled vaccine hesitancy in Sri Lanka.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kamalrathne</LastName><ForeName>Thushara</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4681-2568</Identifier><AffiliationInfo><Affiliation>Global Disaster Resilience Centre, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jayasekara</LastName><ForeName>Jayasekara R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-6677-2279</Identifier><AffiliationInfo><Affiliation>Department of Civil and Environmental Engineering, Louisiana State University, Baton Rouge, LA 70803, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amaratunga</LastName><ForeName>Dilanthi</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Global Disaster Resilience Centre, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haigh</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Global Disaster Resilience Centre, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield HD1 3DH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kodituwakku</LastName><ForeName>Lahiru</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ministry of Health, Colombo 01000, Sri Lanka.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rupasinghe</LastName><ForeName>Chintha</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-3157-0383</Identifier><AffiliationInfo><Affiliation>Ministry of Health, Colombo 01000, Sri Lanka.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>EP/V026038/1</GrantID><Agency>UKRI</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Environ Res Public Health</MedlineTA><NlmUniqueID>101238455</NlmUniqueID><ISSNLinking>1660-4601</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013188" MajorTopicYN="N" Type="Geographic">Sri Lanka</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088823" MajorTopicYN="Y">Vaccination Hesitancy</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="Y">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033181" MajorTopicYN="Y">Information Dissemination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012959" MajorTopicYN="N">Socioeconomic Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">determinants of vaccine hesitancy</Keyword><Keyword MajorTopicYN="N">public health information</Keyword><Keyword MajorTopicYN="N">public health knowledge</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy</Keyword><Keyword MajorTopicYN="N">vaccine hesitancy in Sri Lanka</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457242</ArticleId><ArticleId IdType="pmc">PMC11507827</ArticleId><ArticleId IdType="doi">10.3390/ijerph21101268</ArticleId><ArticleId IdType="pii">ijerph21101268</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Piret J., Boivin G. Pandemics Throughout History. Front. Microbiol. 2021;11:631736. doi: 10.3389/fmicb.2020.631736.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.631736</ArticleId><ArticleId IdType="pmc">PMC7874133</ArticleId><ArticleId IdType="pubmed">33584597</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . SARS-CoV-2 Variants-Disease Outbreak News: 31 December 2020. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>El-Shabasy R.M., Nayel M.A., Taher M.M., Abdelmonem R., Shoueir K.R., Kenawy E.R. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int. J. Biol. Macromol. 2022;204:161–168. doi: 10.1016/j.ijbiomac.2022.01.118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2022.01.118</ArticleId><ArticleId IdType="pmc">PMC8782737</ArticleId><ArticleId IdType="pubmed">35074332</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubé E., Laberge C., Guay M., Bramadat P., Roy R., Bettinger J.A. Vaccine hesitancy. Hum. Vaccines Immunother. 2013;9:1763–1773. doi: 10.4161/hv.24657.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/hv.24657</ArticleId><ArticleId IdType="pmc">PMC3906279</ArticleId><ArticleId IdType="pubmed">23584253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamalrathne T., Amaratunga D., Haigh R., Kodituwakku L. Need for effective detection and early warnings for epidemic and pandemic preparedness planning in the context of multi-hazards: Lessons from the COVID-19 pandemic. Int. J. Disaster Risk Reduct. 2023;92:103724. doi: 10.1016/j.ijdrr.2023.103724.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdrr.2023.103724</ArticleId><ArticleId IdType="pmc">PMC10148710</ArticleId><ArticleId IdType="pubmed">37197332</ArticleId></ArticleIdList></Reference><Reference><Citation>Watson O.J., Barnsley G., Toor J., Hogan A.B., Winskill P., Ghani A.C. Global impact of the first year of COVID-19 vaccination: A mathematical modelling study. Lancet Infect. Dis. 2022;22:1293–1302. doi: 10.1016/S1473-3099(22)00320-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00320-6</ArticleId><ArticleId IdType="pmc">PMC9225255</ArticleId><ArticleId IdType="pubmed">35753318</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO  . WHO Coronavirus (COVID-19) Dashboard-Vaccination Status. World Health Organization; 2023.  [(accessed on 4 May 2023)].  [Online] Available online:  https://covid19.who.int/?mapFilter=vaccinations.</Citation></Reference><Reference><Citation>Edouard M., Ritchie H., Rodés-Guirao L., Appel C., Giattino C., Hasell J., Macdonald B., Dattani S., Beltekian D., Ortiz-Ospina E., et al.  Coronavirus Pandemic (COVID-19) Our World in Data. 2020.  [(accessed on 12 July 2021)].  Available online:  https://ourworldindata.org/coronavirus.</Citation></Reference><Reference><Citation>WHO . Infodemic Management: An Overview of Infodemic Management during COVID-19. World Health Organization; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Broniatowski D.A., Dredze M., Ayers J.W. “First Do No Harm”: Effective Communication About COVID-19 Vaccines. Am. J. Public Health. 2021;111:1055–1057. doi: 10.2105/AJPH.2021.306288.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2021.306288</ArticleId><ArticleId IdType="pmc">PMC8101564</ArticleId><ArticleId IdType="pubmed">33950727</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges Do Nascimento I.J., Pizarro A.B., Almeida J.M., Azzopardi-Muscat N., Gonçalves M.A., Björklund M., Novillo-Ortiz D. Infodemics and health misinformation: A systematic review of reviews. Bull. World Health Organ. 2022;100:544–561. doi: 10.2471/BLT.21.287654.</Citation><ArticleIdList><ArticleId IdType="doi">10.2471/BLT.21.287654</ArticleId><ArticleId IdType="pmc">PMC9421549</ArticleId><ArticleId IdType="pubmed">36062247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornwall W. Officials gird for a war on vaccine misinformation. Science. 2020;369:14–15. doi: 10.1126/science.369.6499.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.369.6499.14</ArticleId><ArticleId IdType="pubmed">32631873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S.K., Sun J., Jang S., Connelly S. Misinformation of COVID-19 vaccines and vaccine hesitancy. Sci. Rep. 2022;12:13681. doi: 10.1038/s41598-022-17430-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17430-6</ArticleId><ArticleId IdType="pmc">PMC9366757</ArticleId><ArticleId IdType="pubmed">35953500</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpiano R.M., Callaghan T., Diresta R., Brewer N.T., Clinton C., Galvani A.P., Lakshmanan R., Parmet W.E., Omer S.B., Buttenheim A.M., et al. Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era. Lancet. 2023;401:967–970. doi: 10.1016/S0140-6736(23)00136-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00136-8</ArticleId><ArticleId IdType="pmc">PMC9981160</ArticleId><ArticleId IdType="pubmed">36871571</ArticleId></ArticleIdList></Reference><Reference><Citation>To Q.G., To K.G., Huynh V.N., Nguyen N.T., Ngo D.T., Alley S., Tran A.N., Tran A.N., Pham N.T., Bui T.X., et al. Anti-vaccination attitude trends during the COVID-19 pandemic: A machine learning-based analysis of tweets. Digit. Health. 2023;9:20552076231158033. doi: 10.1177/20552076231158033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20552076231158033</ArticleId><ArticleId IdType="pmc">PMC9941594</ArticleId><ArticleId IdType="pubmed">36825077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bechini A., Bonanni P., Zanella B., Di Pisa G., Moscadelli A., Paoli S., Ancillotti L., Bonito B., Boccalini S. Vaccine Production Process: How Much Does the General Population Know about This Topic? A Web-Based Survey. Vaccines. 2021;9:564. doi: 10.3390/vaccines9060564.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9060564</ArticleId><ArticleId IdType="pmc">PMC8229207</ArticleId><ArticleId IdType="pubmed">34072288</ArticleId></ArticleIdList></Reference><Reference><Citation>Calnan M. Health policy and controlling COVID-19 in England: Sociological insights. Emerald Open Res. 2020;1 doi: 10.1108/EOR-02-2023-0013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1108/EOR-02-2023-0013</ArticleId></ArticleIdList></Reference><Reference><Citation>Raballo A., Poletti M., Preti A. Vaccine Hesitancy, Anti-Vax, COVID-Conspirationism: From Subcultural Convergence to Public Health and Bioethical Problems. Front. Public Health. 2022;10:877490. doi: 10.3389/fpubh.2022.877490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.877490</ArticleId><ArticleId IdType="pmc">PMC9124823</ArticleId><ArticleId IdType="pubmed">35615038</ArticleId></ArticleIdList></Reference><Reference><Citation>Burki T. The online anti-vaccine movement in the age of COVID-19. Lancet Digit. Health. 2020;2:e504–e505. doi: 10.1016/S2589-7500(20)30227-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(20)30227-2</ArticleId><ArticleId IdType="pmc">PMC7508526</ArticleId><ArticleId IdType="pubmed">32984795</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinelli M., Quattrociocchi W., Galeazzi A., Valensise C.M., Brugnoli E., Schmidt A.L., Zola P., Zollo F., Scala A. The COVID-19 social media infodemic. Sci. Rep. 2020;10:16598. doi: 10.1038/s41598-020-73510-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73510-5</ArticleId><ArticleId IdType="pmc">PMC7538912</ArticleId><ArticleId IdType="pubmed">33024152</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasnim S., Hossain M.M., Mazumder H. Impact of Rumors and Misinformation on COVID-19 in Social Media. J. Prev. Med. Public Health. 2020;53:171–174. doi: 10.3961/jpmph.20.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.3961/jpmph.20.094</ArticleId><ArticleId IdType="pmc">PMC7280809</ArticleId><ArticleId IdType="pubmed">32498140</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson S.L., Wiysonge C. Social media and vaccine hesitancy. BMJ Glob. Health. 2020;5:e004206. doi: 10.1136/bmjgh-2020-004206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2020-004206</ArticleId><ArticleId IdType="pmc">PMC7590343</ArticleId><ArticleId IdType="pubmed">33097547</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado A.Y. Lessons From a House on Fire—From Smallpox to Polio. J. Infect. Dis. 2023;227:1025–1027. doi: 10.1093/infdis/jiad017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad017</ArticleId><ArticleId IdType="pubmed">36691964</ArticleId></ArticleIdList></Reference><Reference><Citation>Nuwarda R.F., Ramzan I., Weekes L., Kayser V. Vaccine Hesitancy: Contemporary Issues and Historical Background. Vaccines. 2022;10:1595. doi: 10.3390/vaccines10101595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101595</ArticleId><ArticleId IdType="pmc">PMC9612044</ArticleId><ArticleId IdType="pubmed">36298459</ArticleId></ArticleIdList></Reference><Reference><Citation>Razai M.S., Chaudhry U.A.R., Doerholt K., Bauld L., Majeed A. COVID-19 vaccination hesitancy. BMJ. 2021;373:n1138. doi: 10.1136/bmj.n1138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1138</ArticleId><ArticleId IdType="pubmed">34016653</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Vaccine Hesitancy: A Growing Challenge for Immunization Programmes. World Health Organization; Geneva, Switzerland: 2015.</Citation></Reference><Reference><Citation>Hickler B., Guirguis S., Obregon R. Vaccine Special Issue on Vaccine Hesitancy. Vaccine. 2015;33:4155–4156. doi: 10.1016/j.vaccine.2015.04.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.034</ArticleId><ArticleId IdType="pubmed">25896381</ArticleId></ArticleIdList></Reference><Reference><Citation>Macdonald N.E. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–4164. doi: 10.1016/j.vaccine.2015.04.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.036</ArticleId><ArticleId IdType="pubmed">25896383</ArticleId></ArticleIdList></Reference><Reference><Citation>SAGE  Report of the Sage Working Group on Vaccine Hesitancy. 2014.  [(accessed on 12 July 2021)].  Available online:  https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf.</Citation></Reference><Reference><Citation>Butler R., Macdonald N.E. Diagnosing the determinants of vaccine hesitancy in specific subgroups: The Guide to Tailoring Immunization Programmes (TIP) Vaccine. 2015;33:4176–4179. doi: 10.1016/j.vaccine.2015.04.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.04.038</ArticleId><ArticleId IdType="pubmed">25896376</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid P., Rauber D., Betsch C., Lidolt G., Denker M.L. Barriers of Influenza Vaccination Intention and Behavior—A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PLoS ONE. 2017;12:e0170550. doi: 10.1371/journal.pone.0170550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170550</ArticleId><ArticleId IdType="pmc">PMC5268454</ArticleId><ArticleId IdType="pubmed">28125629</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus J.V., Wyka K., White T.M., Picchio C.A., Gostin L.O., Larson H.J., Rabin K., Ratzan S.C., Kamarulzaman A., EL-Mohandes A. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat. Med. 2023;29:366–375. doi: 10.1038/s41591-022-02185-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02185-4</ArticleId><ArticleId IdType="pubmed">36624316</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallam M. COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates. Vaccines. 2021;9:160. doi: 10.3390/vaccines9020160.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9020160</ArticleId><ArticleId IdType="pmc">PMC7920465</ArticleId><ArticleId IdType="pubmed">33669441</ArticleId></ArticleIdList></Reference><Reference><Citation>Shakeel C.S., Mujeeb A.A., Mirza M.S., Chaudhry B., Khan S.J. Global COVID-19 Vaccine Acceptance: A Systematic Review of Associated Social and Behavioral Factors. Vaccines. 2022;10:110. doi: 10.3390/vaccines10010110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010110</ArticleId><ArticleId IdType="pmc">PMC8779795</ArticleId><ArticleId IdType="pubmed">35062771</ArticleId></ArticleIdList></Reference><Reference><Citation>MOH . Coronavirus Disease 2019 (COVID-19)-Situation Report-7.5.2023. Epidemiology Unit, Ministry of Health; Colombo, Sri Lanka: 2023.</Citation></Reference><Reference><Citation>Amaratunga D., Fernando N., Haigh R., Jayasinghe N. The COVID-19 outbreak in Sri Lanka: A synoptic analysis focusing on trends, impacts, risks and science-policy interaction processes. Prog. Disaster Sci. 2020;8:100133. doi: 10.1016/j.pdisas.2020.100133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pdisas.2020.100133</ArticleId><ArticleId IdType="pmc">PMC7836425</ArticleId><ArticleId IdType="pubmed">34173449</ArticleId></ArticleIdList></Reference><Reference><Citation>Galappaththi E.K., Perera C.D., Dharmasiri I.P., Ford J.D., Kodithuwakku S.S., Chicmana-Zapata V., Zavaleta-Cortijo C., Pickering K., Van Bavel B., Hyams K., et al. Policy responses to COVID-19 in Sri Lanka and the consideration of Indigenous Peoples. Environ. Sci. Policy. 2023;144:110–123. doi: 10.1016/j.envsci.2023.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envsci.2023.03.008</ArticleId><ArticleId IdType="pmc">PMC10011033</ArticleId><ArticleId IdType="pubmed">36949900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamalrathne T., Amaratunga D., Haigh R., Amaratunga D., Haigh R. A more decentralized governance framework for pandemic response: A multi-stakeholder approach for COVID-19 preparedness and planning in Sri Lanka. In: Ranjith Senaratne D.A., Shanthi M., Premachandra A., editors. COVID 19: Impact, Mitigation, Opportunities and Building Resilience: From Adversity to Serendipity-Perspectives of Global Relevance Based on Research, Experience and Successes in Combating COVID-19 in Sri Lanka. National Science Foundation; Colombo, Sri Lanka: 2021.</Citation></Reference><Reference><Citation>Rannan-Eliya R.P., Ghaffoor A., Amarasinghe S., Nirmani M.D., Wijemunige N., Perera S., Samarage S., Dalpatadu K., Wisidagama N., Fonseka S., et al. Sri Lanka’s COVID-19 response and maintaining health services: Implications for future pandemics. BMJ Glob. Health. 2024;8((Suppl. S6)):e013286. doi: 10.1136/bmjgh-2023-013286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2023-013286</ArticleId><ArticleId IdType="pmc">PMC10846852</ArticleId><ArticleId IdType="pubmed">38238029</ArticleId></ArticleIdList></Reference><Reference><Citation>MOH  . High Endemic Diseases/Outbreaks. Epidemiology Unit, Ministry of Health; Colombo, Sri Lanka: 2023.  [(accessed on 8 May 2023)].  [Online] Available online:  https://www.epid.gov.lk/high-endemic-diseases-outbreaks.</Citation></Reference><Reference><Citation>Swarnamali H., Francis T.V., Sooriyaarachchi P., Jayawardena R. COVID-19 vaccine hesitancy in Sri Lanka: A national level survey. Int. J. Health Sci. 2023;17:3–11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9832912</ArticleId><ArticleId IdType="pubmed">36704496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesinghe M.S.D., Weerasinghe W.M.P.C., Gunawardana I., Perera S.N.S., Karunapema R.P.P. Acceptance of COVID-19 Vaccine in Sri Lanka: Applying the Health Belief Model to an Online Survey. Asia Pac. J. Public Health. 2021;33:598–602. doi: 10.1177/10105395211014975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10105395211014975</ArticleId><ArticleId IdType="pubmed">34000877</ArticleId></ArticleIdList></Reference><Reference><Citation>DCS   [(accessed on 6 April 2024)];Estimated Mid Year Population by District. 2023  [Online]. Department of Census and Statistics in Sri Lanka. Available online:  https://www.rgd.gov.lk/web/images/2023/vitalStat/MidYearPopulation/Mid-year-population-by-district--Sex.pdf.</Citation></Reference><Reference><Citation>Barlett J.E., Kotrlik J.W., Higgins C.C. Organizational research: Determining appropriate sample size in survey research. Inf. Technol. Learn. Perform. J. 2001;19:43–50.</Citation></Reference><Reference><Citation>MCFADDEN D. Quantitative methods for Analysing travel behaviour of individuals: Some recent developments. In: Hensher D., Stopher P., editors. Behavioural Travel Modelling. Routledge; London, UK: 1979. pp. 279–318.</Citation></Reference><Reference><Citation>Marsoof A. The Disposal of COVID-19 Dead Bodies: Impact of Sri Lanka’s Response on Fundamental Rights. J. Hum. Rights Pract. 2022;13:669–689. doi: 10.1093/jhuman/huab030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jhuman/huab030</ArticleId><ArticleId IdType="pmc">PMC8992289</ArticleId><ArticleId IdType="pubmed">35432600</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues C.M.C., Plotkin S.A. Impact of Vaccines; Health, Economic and Social Perspectives. Front. Microbiol. 2020;11:1526. doi: 10.3389/fmicb.2020.01526.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01526</ArticleId><ArticleId IdType="pmc">PMC7371956</ArticleId><ArticleId IdType="pubmed">32760367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan S.T., Kwan A.T., Rodríguez-Barraquer I., Singer B.J., Park H.J., Lewnard J.A., Sears D., Lo N.C. Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave. Nat. Med. 2023;29:358–365. doi: 10.1038/s41591-022-02138-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02138-x</ArticleId><ArticleId IdType="pmc">PMC9974584</ArticleId><ArticleId IdType="pubmed">36593393</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath P.T., Galiza E.P., Baxter D.N., Boffito M., Browne D., Burns F., Chadwick D.R., Clark R., Cosgrove C.A., Galloway J., et al. Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial. Clin. Infect. Dis. 2023;76:398–407. doi: 10.1093/cid/ciac803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac803</ArticleId><ArticleId IdType="pmc">PMC9619635</ArticleId><ArticleId IdType="pubmed">36210481</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews N., Stowe J., Kirsebom F., Toffa S., Rickeard T., Gallagher E., Gower C., Kall M., Groves N., O’Connell A.M., et al. covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N. Engl. J. Med. 2022;386:1532–1546. doi: 10.1056/NEJMoa2119451.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2119451</ArticleId><ArticleId IdType="pmc">PMC8908811</ArticleId><ArticleId IdType="pubmed">35249272</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong L.P., Alias H., Danaee M., Ahmed J., Lachyan A., Cai C.Z., Lin Y., Hu Z., Tan S.Y., Lu Y., et al. COVID-19 vaccination intention and vaccine characteristics influencing vaccination acceptance: A global survey of 17 countries. Infect. Dis. Poverty. 2021;10:122. doi: 10.1186/s40249-021-00900-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00900-w</ArticleId><ArticleId IdType="pmc">PMC8496428</ArticleId><ArticleId IdType="pubmed">34620243</ArticleId></ArticleIdList></Reference><Reference><Citation>Azarpanah H., Farhadloo M., Vahidov R., Pilote L. Vaccine hesitancy: Evidence from an adverse events following immunization database, and the role of cognitive biases. BMC Public Health. 2021;21:1686. doi: 10.1186/s12889-021-11745-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-11745-1</ArticleId><ArticleId IdType="pmc">PMC8444164</ArticleId><ArticleId IdType="pubmed">34530804</ArticleId></ArticleIdList></Reference><Reference><Citation>Manilgama S.R., Hettiarachchi N.M., Jayasinghe K.I., De Silva S., Wanigaratne T., Jayalath T., Bandusiri R.P., Suganthan N., Sudarshan P., Pathirage M., et al. Prevalence of Covishield COVID-19 Vaccine (ChAdOx1 nCoV-19) Adverse Effects among Health Care Workers in Sri Lanka. Int. J. Infect. Dis. 2022;116:S61. doi: 10.1016/j.ijid.2021.12.143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.12.143</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer R.D. COVID 19 vaccines and the misinterpretation of perceived side effects clarity on the safety of vaccines. BioMedicine. 2022;12:1–4. doi: 10.37796/2211-8039.1371.</Citation><ArticleIdList><ArticleId IdType="doi">10.37796/2211-8039.1371</ArticleId><ArticleId IdType="pmc">PMC9629406</ArticleId><ArticleId IdType="pubmed">36381188</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M.C.S., Wong E.L.Y., Huang J., Cheung A.W.L., Law K., Chong M.K.C., Ng R.W.Y., Lai C.K.C., Boon S.S., Lau J.T.F., et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39:1148–1156. doi: 10.1016/j.vaccine.2020.12.083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2020.12.083</ArticleId><ArticleId IdType="pmc">PMC7832076</ArticleId><ArticleId IdType="pubmed">33461834</ArticleId></ArticleIdList></Reference><Reference><Citation>Seara-Morais G.J., Avelino-Silva T.J., Couto M., Avelino-Silva V.I. The pervasive association between political ideology and COVID-19 vaccine uptake in Brazil: An ecologic study. BMC Public Health. 2023;23:1606. doi: 10.1186/s12889-023-16409-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-16409-w</ArticleId><ArticleId IdType="pmc">PMC10464231</ArticleId><ArticleId IdType="pubmed">37612648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hâncean M.-G., Lerner J., Perc M., Molina J.L., Geantă M. Assortative mixing of opinions about COVID-19 vaccination in personal networks. Sci. Rep. 2024;14:3385. doi: 10.1038/s41598-024-53825-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-53825-3</ArticleId><ArticleId IdType="pmc">PMC10858210</ArticleId><ArticleId IdType="pubmed">38336858</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsuwaidi A.R., Hammad H.A.A.-K., Elbarazi I., Sheek-Hussein M. Vaccine hesitancy within the Muslim community: Islamic faith and public health perspectives. Hum. Vaccines Immunother. 2023;19:2190716. doi: 10.1080/21645515.2023.2190716.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2023.2190716</ArticleId><ArticleId IdType="pmc">PMC10038058</ArticleId><ArticleId IdType="pubmed">36914409</ArticleId></ArticleIdList></Reference><Reference><Citation>Benoit S.L., Mauldin R.F. The “anti-vax” movement: A quantitative report on vaccine beliefs and knowledge across social media. BMC Public Health. 2021;21:2106. doi: 10.1186/s12889-021-12114-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-021-12114-8</ArticleId><ArticleId IdType="pmc">PMC8596085</ArticleId><ArticleId IdType="pubmed">34789206</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin F., Chen X., Cheng E.W. Contextualized impacts of an infodemic on vaccine hesitancy: The moderating role of socioeconomic and cultural factors. Inf. Process. Manag. 2022;59:103013. doi: 10.1016/j.ipm.2022.103013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ipm.2022.103013</ArticleId><ArticleId IdType="pmc">PMC9286777</ArticleId><ArticleId IdType="pubmed">35874146</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha Y.M., de Moura G.A., Desidério G.A., de Oliveira C.H., Lourenço F.D., de Figueiredo Nicolete L.D. The impact of fake news on social media and its influence on health during the COVID-19 pandemic: A systematic review. J. Public Health. 2021;31:1007–1016. doi: 10.1007/s10389-021-01658-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10389-021-01658-z</ArticleId><ArticleId IdType="pmc">PMC8502082</ArticleId><ArticleId IdType="pubmed">34660175</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervi L., Tejedor Calvo S., Robledo-Dioses K. Digital communication and the city. Analysis of the websites of the most visited cities in the world in the COVID-19 era. Rev. Lat. Comun. Soc. 2023;81:81–108. doi: 10.4185/RLCS-2023-1845.</Citation><ArticleIdList><ArticleId IdType="doi">10.4185/RLCS-2023-1845</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayakarathna S. Freedom Fights Fake: Sri Lanka’s Fight against the ‘Infodemic’ during the Pandemic. 2021.  [(accessed on 26 March 2023)].  Available online:  https://www.freiheit.org/sri-lanka/sri-lankas-fight-against-infodemic-during-pandemic.</Citation></Reference><Reference><Citation>Balgiu B.A., Sfeatcu R.T., Âncu A.M.C., Imre M., Petre A., Tribus L. The Multidimensional Vaccine Hesitancy Scale: A Validation Study. Vaccines. 2022;10:1755. doi: 10.3390/vaccines10101755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101755</ArticleId><ArticleId IdType="pmc">PMC9608997</ArticleId><ArticleId IdType="pubmed">36298620</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard M.C. A more comprehensive measure of vaccine hesitancy: Creation of the Multidimensional Vaccine Hesitancy Scale (MVHS) J. Health Psychol. 2022;27:2402–2419. doi: 10.1177/13591053211042062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/13591053211042062</ArticleId><ArticleId IdType="pubmed">34474616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotta I., Kalcza-Janosi K., Szabo K., Marschalko E.E. Development and Validation of the Multidimensional COVID-19 Vaccine Hesitancy Scale. Hum. Vaccines Immunother. 2022;18:1–10. doi: 10.1080/21645515.2021.2007708.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2021.2007708</ArticleId><ArticleId IdType="pmc">PMC8928857</ArticleId><ArticleId IdType="pubmed">34919494</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>